Paula Roberta DA Silva

Paula Roberta DA Silva

Auto-generated profile, based on publicly available information

Paula Roberta DA Silva

Universidade Federal de Pernambuco, Brasil

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
PDF file
KSKeriolaine L. DOS Santos
Keriolaine L. DOS Santos
DMDiego Santa Clara Marques
Diego Santa Clara Marques
IJIris T. Jacob
Iris T. Jacob
PSPaula Roberta DA Silva
Paula Roberta DA Silva
DMDijanah C. Machado
Dijanah C. Machado
MLMaria Do Carmo Alves De Lima
Maria Do Carmo Alves De Lima
Cancer is a complex and multifactorial disease characterized by uncontrolled cell growth and is one of the main causes of death in the world. This work aimed to evaluate a small series of 10 different indole-thiosemicarbazone compounds as potential antitumor agents. This is a pioneering study. For this, the antioxidant and cytotoxic capacity against normal and tumor cells was evaluated. The results showed that the compounds were able to promote moderate to low antioxidant activity for the ABTS radical scavenging assay. ADMET in silico assays showed that the compounds exhibited good oral bioavailability. As for toxicity, they were able to promote low cytotoxicity against normal cells, in addition to not being hemolytic. The compounds showed promising in vitro antitumor activity against the T47D, MCF-7, Jurkat and DU-145 strains, not being able to inhibit the growth of the Hepg2 strain. Through this in vitro study, it can be concluded that the compounds are potential candidates for antitumor agents.

1 January 2025 in Brazilian Archives of Biology and Technology
Verified
Journal Article
Open access
PDF file
KSKeriolaine Lima dos Santos
Keriolaine Lima dos Santos
DMDiego Santa Clara Marques
Diego Santa Clara Marques
IJIris Trindade Jacob
Iris Trindade Jacob
PSPaula Roberta da Silva
Paula Roberta da Silva
DMDijanah Cota Machado
Dijanah Cota Machado
MLMaria Do Carmo Alves De Lima
Maria Do Carmo Alves De Lima
Indole-thiosemicarbazones have different biological activities. The present study evaluated the preliminary interaction of these compounds with biomolecules, specifically human serum albumin (HSA) and DNA, using fluorescence techniques. The suppression results (Ksv) for HSA ranged from 3.5 x 104 to 4.6 x 105 L/mol, while for DNA, they ranged from 1.4 x 104 to 5.9 x 104 L/mol. The suppression was classified as weak to strong for HSA and moderate for DNA. The bimolecular suppression constant (Kq) showed values between 6.0 x 1012 and 8.2 x 1013 L/mol/s for HSA and from 1.4 x 1012 to 5.9 x 1012 L/mol/s for DNA, suggesting a static suppression mechanism. Compound PR09 stood out, presenting a binding constant (Ka) greater than 105 L/mol for HSA, indicating a strong interaction. Additionally, PR05, PR06, PR07, and PR09 demonstrated strong interactions with DNA. The values of the number of binding sites (n) indicated that PR01, PR02, and PR09 bind to multiple sites on HSA, while PR04, PR05, PR06, and PR09 interact with more than one site on DNA. All interactions were spontaneous, with ∆G negative. The distance between the compounds and tryptophan on HSA was less than 8 nm, suggesting high energy transfer efficiency. In molecular docking studies, PR05 showed the highest affinity for DNA (-11.15 kcal/mol), while PR09 had the highest affinity for HSA (-10.00 kcal/mol). PR07 exhibited the lowest binding energies for DNA (-8.21 kcal/mol) and for HSA (-7.38 kcal/mol). This study demonstrates that the evaluated compounds have potential as new drug candidates.